Document is current
Any future updates will be listed below
-
Authors
Altrichter, Sabine http://orcid.org/0000-0001-9955-385X
Schumacher, Pia
Alraboni, Ola
Wang, Yiyu
Hiragun, Makiko
Hide, Michihiro
Maurer, Marcus http://orcid.org/0000-0002-4121-481X
-
Funding
Funding for this research was provided by:
Charité – Universitätsmedizin Berlin (intramural funding)
- License Information
-
More Information
Article History
Received: 9 March 2020
Accepted: 16 May 2020
First Online: 1 June 2020
Ethics approval and consent to participate
: The study was approved by the Ethics Committee of the Charité-Universitätsmedizin Berlin (EA4/124/10).
: Not applicable.
: Sabine Altrichter is or recently was a speaker and/or advisor for and/or has received research funding from Allakos, AstraZeneca, Moxie, Sanofi and Novartis. Yiyu Wang, Ola Alraboni, Pia Schumacher, Makiko Hiragun has no competing interests. Mchihiro Hide is or recently was a speaker and/or advisor for and/or has received research funding from. Marcus Maurer is or recently was a speaker and/or advisor for and/or has received research funding from Allakos, Aralez, Genentech, GSK, Menarini, Merckle Recordati, Moxie, Novartis, Sanofi, MSD, and Uriach.
